Astellas, Seeking Sales in India, Opens Mumbai Office (India)
This article was originally published in PharmAsia News
Executive Summary
Astellas Pharma Inc. recently opened the doors of an office in Mumbai, India. The new facility offers Astellas a major opportunity to access the fast growing Indian pharmaceutical market. Currently, the country's drug market is valued at $6.2 billion, making it the number four market in Asia. According to projections by McKinsey & Co. that figure will soar 12 percent every year to $20 billion in 2015. The Asian market outside of Japan presently makes up only 3 percent of Astellas' revenue, a fact the company plans to change in the face of tightening drug pricing restrictions in Japan. (Click here for more - May Require Free Registration